New research in mice reveals how THC, the main psychoactive compound in cannabis, can reduce the effectiveness of risperidone, an antipsychotic drug used widely to treat people with schizophrenia.
Several new genome-wide investigations of schizophrenia and substance-use disorders are helping researchers understand how these two conditions may be related, according to a paper published in
A small pilot study published September 17, 2017 in Psychiatry Research finds that marijuana can cause a temporary increase in psychotic-like states in people who are at high clinical risk fo
Donations are welcome
100% of every dollar donated for research is invested in our research grants. Our operating expenses are covered by separate foundation grants.
The Brain & Behavior Research Foundation is a 501(c)(3) nonprofit organization, our Tax ID # is 31-1020010.